Total Funding
69
67
Total FundingCorporate Round raised
Growth Score 69 in past quarter
-9 pts
Heat Score 67 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61786
Orano Med develops targeted therapies against cancers.
- Frédéric Desdouits: Chief Executive OfficerPast Role: TreeFrog Therapeutics, Chief Executive Officer
- Volker Wagner: Chief Medical Officer
About the Company
Orano Med develops a new generation of targeted cancer therapies. The Orano Med company specializes in performance chelating agents, offering a broad range of products and services. The Orano Med strategy centers on creating a solid portfolio of therapies and ensuring a reliable supply of isotopes.